Price T Rowe Associates Inc Portfolio Holdings

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Price T Rowe Associates Inc has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $869 Billion distributed in 4516 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $58.4B, Apple Inc. with a value of $54.9B, Nvidia Corp with a value of $49.5B, Amazon Com Inc with a value of $33.3B, and Meta Platforms, Inc. with a value of $23.6B.

Examining the 13F form we can see an increase of $32.9B in the current position value, from $836B to 869B.

Price T Rowe Associates Inc is based out at Baltimore, MD

Below you can find more details about Price T Rowe Associates Inc portfolio as well as his latest detailed transactions.

Portfolio value $869 Billion
Technology: $271 Billion
Healthcare: $129 Billion
Financial Services: $91.1 Billion
Consumer Cyclical: $89.9 Billion
Communication Services: $74.6 Billion
Industrials: $67.9 Billion
Energy: $33 Billion
Consumer Defensive: $31.2 Billion
Other: $55.7 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.57B
$983,000 0.0% of portfolio
156,203
Q3 2024 Reduced 18.07%
$801M
$7.41 Million 0.0% of portfolio
1,074,488
Q3 2024 Reduced 37.5%
$12.1B
$11.4 Million 0.0% of portfolio
68,611
Q3 2024 Added 3.57%
$909M
$1.74 Million 0.0% of portfolio
74,913
Q3 2024 Added 4.01%
$3.41B
$1.76 Million 0.0% of portfolio
18,458
Q3 2024 Reduced 2.25%
$1.95B
$1.46 Million 0.0% of portfolio
23,585
Q3 2024 Reduced 10.25%
$0
$1.95 Million 0.0% of portfolio
31,246
Q2 2024 Reduced 39.39%
Durect Corp
-
$20,000 0.0% of portfolio
-
Q1 2023 Added 38.32%
$1.57B
$862,000 0.0% of portfolio
75,351
Q3 2024 Added 1.84%
$29.8B
$1.16 Million 0.0% of portfolio
67,000
Q3 2024 Reduced 8.67%
$4.47B
$7.52 Million 0.0% of portfolio
109,781
Q3 2024 Added 169.95%
$3.55B
$12.7 Million 0.0% of portfolio
250,451
Q3 2024 Added 7.39%
$254M
$456,000 0.0% of portfolio
48,560
Q3 2024 Added 10.4%
$0
$225,000 0.0% of portfolio
17,570
Q3 2024 Reduced 18.93%
$453M
$215,000 0.0% of portfolio
31,715
Q3 2024 Added 4.2%
$1.36B
$1.21 Million 0.0% of portfolio
28,342
Q3 2024 Reduced 9.4%
$2.98B
$2.13 Million 0.0% of portfolio
63,515
Q3 2024 Added 7.51%
$15.7B
$7.04 Million 0.0% of portfolio
79,300
Q3 2024 Added 23.91%
$1.79B
$1.35 Million 0.0% of portfolio
11,894
Q3 2024 Added 1.5%
$124M
$231,000 0.0% of portfolio
25,000
Q4 2023 Added 19.62%
$947M
$356,000 0.0% of portfolio
250,079
Q3 2024 Added 3.02%
$3.24B
$5.91 Million 0.0% of portfolio
82,804
Q3 2024 Added 28.02%
$16.9B
$4.91 Million 0.0% of portfolio
458,690
Q3 2024 Reduced 66.36%
$145M
$184,000 0.0% of portfolio
117,179
Q2 2024 Added 11.27%
$6.64B
$5.09 Million 0.0% of portfolio
58,874
Q3 2024 Added 1.12%
$742M
$942,000 0.0% of portfolio
48,927
Q3 2024 Added 1.51%
$1.55B
$1.01 Million 0.0% of portfolio
113,290
Q3 2024 Added 3.98%
$1B
$25.6 Million 0.0% of portfolio
3,126,604
Q3 2024 Added 117.24%
Workhorse Group Inc
-
$26,000 0.0% of portfolio
-
Q2 2024 New
$3.7B
$4.33 Million 0.0% of portfolio
185,723
Q3 2024 Added 2.0%
$1.7B
$895,000 0.0% of portfolio
106,914
Q3 2024 Added 4.34%
$363M
$102,000 0.0% of portfolio
288,900
Q2 2024 Reduced 21.32%
$2.52B
$15.6 Million 0.0% of portfolio
286,396
Q3 2024 Reduced 1.62%
$1.02B
$326,000 0.0% of portfolio
10,269
Q3 2024 Added 3.74%
$14.1B
$2.97 Million 0.0% of portfolio
19,770
Q3 2024 Added 1.7%
$1.48B
$1.18 Million 0.0% of portfolio
12,332
Q3 2024 Added 31.95%
$1.45B
$1.28 Million 0.0% of portfolio
32,697
Q3 2024 Added 1.03%
$1.37B
$799,000 0.0% of portfolio
23,438
Q3 2024 Added 1.66%
$324M
$168,000 0.0% of portfolio
126,648
Q2 2024 Added 111.43%
$424M
$774,000 0.0% of portfolio
26,997
Q3 2024 Reduced 8.03%
Oruka Therapeutics Inc
-
$6.86 Million 0.0% of portfolio
-
Q3 2024 New
$11.5B
$7.54 Million 0.0% of portfolio
50,421
Q3 2024 Added 5.52%
$15.1B
$27.3 Million 0.0% of portfolio
443,733
Q3 2024 Added 86.73%
$0
$1.88 Million 0.0% of portfolio
6,627
Q3 2024 Added 1.66%
Spyre Therapeutics Inc
-
$12.6 Million 0.0% of portfolio
-
Q3 2024 Added 39.34%
$3.72B
$2.38 Million 0.0% of portfolio
37,063
Q3 2024 Reduced 42.9%
$33.7B
$4.03 Million 0.0% of portfolio
51,169
Q3 2024 Added 9.72%
$491M
$383,000 0.0% of portfolio
23,705
Q3 2024 Added 0.91%
$4.39B
$32.3 Million 0.0% of portfolio
987,214
Q3 2024 Reduced 2.09%

Summary

  • Portfolio
  • No. of Stocks 4,516
  • Current Value $869 Billion
  • Prior Value $836 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 99 stocks
  • Additional Purchases 1,775 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 866 stocks
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email